Hims & Hers Health Stock Discussion

$Hims & Hers Health (HIMS.US)$ great buy

Nice move up on earnings. Watch for the GAP to be tested tomorrow.
Larger Image: tradingview.com...
$Hims & Hers Health (HIMS.US)$  

$Hims & Hers Health (HIMS.US)$ On conference call Hims & Hers Health Says It Plans to Bring Liraglutide the First Generic GLP-1 in the Market to the Platform in 2025?

$Hims & Hers Health (HIMS.US)$ & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
Revenue of $401.6 million, up 77% year-over-year in Q3 2024
Net income of $75.6 million; Adjusted EBITDA of $51.1 million in Q3 2024
Subscribers grew to 2.0 million, up 44% year-over-year in Q3 2024
Raises full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million

$Hims & Hers Health (HIMS.US)$
Whoa what happened?

$Hims & Hers Health (HIMS.US)$ up up down down right left right left b a b a select start